Skip to main content
Figure 3 | BMC Surgery

Figure 3

From: Effect of pre- and post-treatment α-fetoprotein levels and tumor size on survival of patients with hepatocellular carcinoma treated by resection, transarterial chemoembolization or radiofrequency ablation: a retrospective study

Figure 3

Correlations between studied variables and recurrent tumor size in patients who underwent HR. (a) Pre-treatment serum AFP level (AFPT0) and recurrent tumor size (RTS) were not correlated (r = 0.206, P > 0.05). (b) Recurrent tumor size (TST0) and RTS were not correlated (r = 0.101, P > 0.05). (c) The 3-month post-treatment serum level (AFTT3) and RTS were not correlated (r = 0.251, P > 0.05).

Back to article page